Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle

Journal of Endocrinology

Volumn 187, Issue 1, 2005, Pages 103-108

  Dabrosin, Charlotta ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE; PROGESTERONE;

ADULT; ARTICLE; BREAST; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; MICRODIALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SUBCUTANEOUS FAT;

ADULT; BREAST; ESTRADIOL; EXTRACELLULAR SPACE; FEMALE; HUMANS; LINEAR MODELS; LUTEAL PHASE; MICRODIALYSIS; PROGESTERONE; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 27644500107     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06163     Document Type: Article

References (35)

1. Adamski J & Jakob FJ 2001 A guide to 17 beta-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology 171 1-4.
2. Anderson TJ, Ferguson DJ & Raab GM 1982 Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. British Journal of Cancer 46 376-382.
3. Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 419-427.
4. Chatterton Jr RT, Geiger AS, Gann PH & Khan SA 2003 Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. Journal of Steroid Biochemistry and Molecular Biology 86 159-166.
5. Chen S, Itoh T, Wu K, Zhou D & Yang C 2002 Transcriptional regulation of aromatase expression in human breast tissue. Journal of Steroid Biochemistry and Molecular Biology 83 93-99.
6. Chetrite GS & Pasqualini JR 2001 The selective estrogen enzyme modulator (SEEM) in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 76 95-104.
7. Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F & Pasqualini JR 2000 Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. Journal of Steroid Biochemistry and Molecular Biology 72 23-27.
8. Dabrosin C 2001 Technical aspects of microdialysis of human breast. Scandinavian Journal of Clinical and Laboratory Investigation 61 269-272.
9. Dabrosin C 2003 Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 88 2695-2698.
10. Dabrosin C, Hallstrom A, Ungerstedt U & Hammar M 1997a Microdialysis of human breast tissue during the menstrual cycle. Clinical Science (London) 92 493-496.
11. Dabrosin C, Ollinger K, Ungerstedt U & Hammar M 1997b Variability of glutathione levels in normal breast tissue and subcutaneous fat during the menstrual cycle: an in vivo study with microdialysis technique. Journal of Clinical Endocrinology and Metabolism 82 1382-1384.
12. Fishman J, Nisselbaum JS, Menendez-Botet CJ & Schwartz MK 1977 Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. Journal of Steroid Biochemistry 8 893-896.
13. Geisler J 2003 Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. Journal of Steroid Biochemistry and Molecular Biology 86 245-253.
14. Hawkins RA, Thomson ML & Killen E 1985 Oestrone sulphate, adipose tissue, and breast cancer. Breast Cancer Research and Treatment 6 75-87.
15. Key TJ 1999 Serum oestradiol and breast cancer risk. Endocrine-Related Cancer 6 175-180.
16. Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL & Castracane VD 2003 Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin. Fertility and Sterility 79 534-542.
17. van Landeghem AA, Poortman J, Nabuurs M & Thijssen JH 1985 Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Research 45 2900-2906.
18. Liehr JG 2000 Is estradiol a genotoxic mutagenic carcinogen? Endocrine Review 21 40-54.
19. Miettinen M, Mustonen M, Poutanen M, Isomaa V, Wickman M, Soderqvist G, Vihko R & Vihko P 1999 17 Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Research and Treatment 57 175-182.
20. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M & Maloche C 1996 Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 1460-1464.
21. Poutanen M, Isomaa V, Kainulainen K & Vihko R 1990 Progestin induction of 17 beta-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast-cancer cell line. International Journal of Cancer 46 897-901.
22. Poutanen M, Isomaa V, Lehto VP & Vihko R 1992a Immunological analysis of 17 beta-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. International Journal of Cancer 50 386-390.
23. Poutanen M, Moncharmont B & Vihko R 1992b 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Research 52 290-294.
24. Poutanen M, Isomaa V, Peltoketo H & Vihko R 1995 Regulation of oestrogen action: role of 17 beta-hydroxysteroid dehydrogenases. Annals of Medicine 27 675-682.
25. Purohit A, Newman SP & Reed MJ 2002 The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Research 4 65-69.
26. Purohit A, Singh A, Ghilchik MW, Serlupi-Crescenzi O & Reed MJ 2003 Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts. British Journal of Cancer 88 630-635.
27. Ranadive GN, Mistry JS,, Damodaran K, Khosravi MJ, Diamandi A, Gimpel T, Castracane VD, Patel S & Stanczyk FZ 1998 Rapid, convenient radioimmunoassay of estrone sulfate. Clinical Chemistry 44 244-249.
28. Rosdahl H, Hamrin K, Ungerstedt U & Henriksson J 1998 Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. American Journal of Physiology - Endocrinology and Metabolism 274 E936-E945.
29. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333.
30. Soderqvist G, Poutanen M, Wickman M, von Schoultz B, Skoog L & Vihko R 1998 17 Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception. Journal of Clinical Endocrinology and Metabolism 83 1190-1193.
31. Turgeon C, Gingras S, Carriere MC, Blais Y, Labrie F & Simard J 1998 Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 65 151-162.
32. Ungerstedt U 1991 Microdialysis-principles and applications for studies in animals and man. Journal of Internal Medicine 230 365-373.
33. Vermeulen A, Deslypere JP & Paridaens R 1986a Steroid dynamics in the normal and carcinomatous mammary gland. Journal of Steroid Biochemistry 25 799-802.
34. Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F & Heuson JC 1986b Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. European Journal of Cancer and Clinical Oncology 22 515-525.
35. Zhou D, Zhou C & Chen S 1997 Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. Journal of Steroid Biochemistry and Molecular Biology 61 273-280.